The FDA announced Feb. 6 it has approved Cablivi for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood-clotting disorder.

Hospitals participating in the second phase of a quality improvement program through the American Heart Association/American Stroke Association reduced their median door-to-needle times for acute ischemic stroke patients from 66 minutes to 51 minutes. And the program is now setting its goals even higher. 

E-cigarette users can now add stroke to the list of risks they incur when they make the choice to vape, according to a study of more than 400,000 Americans.

A study of Native Americans who experienced ischemic stroke showed they carried a high burden of risk factors, nearly all of which grew in prevalence from 2000 to 2016.

Direct oral anticoagulants (DOACs) are on their way to surpassing warfarin as the anticoagulant of choice among Medicaid beneficiaries, despite their higher cost, according to new research published in the Journal of the American College of Cardiology.

The Society for Cardiovascular Angiography and Interventions (SCAI) weighed in on the ongoing debate regarding the long-term safety of paclitaxel-coated balloons and stents on Jan. 25, largely agreeing with the FDA’s stance that the benefits of such devices appear to outweigh the risks until more information becomes available.

About 1 in 5 patients experienced cachexia—or a loss of muscle and body weight—within a year of acute ischemic stroke, according to a small, single-center study published Jan. 24 in the Journal of Cachexia, Sarcopenia and Muscle.

A team of researchers has developed a sugar-based stent that provides structural support during challenging microvascular suturing surgeries. The stent, which is 3D printed to match the diameters of specific arteries, fits inside the adjacent ends of a blood vessel while the stitching process takes place—and then quickly dissolves after blood flow resumes.